The Senate health committee heard final business for the session, advancing several health-related bills to the calendar. Major items included a proposal to phase out DEHP from IV equipment, debate over parental access to adolescent medical and rehabilitation records with expert testimony opposing loss of confidentiality, and a bill to default state scheduling to federal (FDA/DEA) decisions to speed patient access to newly approved drugs.